These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 20578842)
21. Analysis and reproducibility of 3'-Deoxy-3'-[18F]fluorothymidine positron emission tomography imaging in patients with non-small cell lung cancer. Shields AF; Lawhorn-Crews JM; Briston DA; Zalzala S; Gadgeel S; Douglas KA; Mangner TJ; Heilbrun LK; Muzik O Clin Cancer Res; 2008 Jul; 14(14):4463-8. PubMed ID: 18628460 [TBL] [Abstract][Full Text] [Related]
22. Imaging of proliferation in hepatocellular carcinoma with the in vivo marker 18F-fluorothymidine. Eckel F; Herrmann K; Schmidt S; Hillerer C; Wieder HA; Krause BJ; Schuster T; Langer R; Wester HJ; Schmid RM; Schwaiger M; Buck AK J Nucl Med; 2009 Sep; 50(9):1441-7. PubMed ID: 19690030 [TBL] [Abstract][Full Text] [Related]
23. 18F-FLT uptake kinetics in head and neck squamous cell carcinoma: a PET imaging study. Liu D; Chalkidou A; Landau DB; Marsden PK; Fenwick JD Med Phys; 2014 Apr; 41(4):041911. PubMed ID: 24694142 [TBL] [Abstract][Full Text] [Related]
24. Correlation of 18F-FLT and 18F-FDG uptake on PET with Ki-67 immunohistochemistry in non-small cell lung cancer. Yamamoto Y; Nishiyama Y; Ishikawa S; Nakano J; Chang SS; Bandoh S; Kanaji N; Haba R; Kushida Y; Ohkawa M Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1610-6. PubMed ID: 17530250 [TBL] [Abstract][Full Text] [Related]
25. A Phase II Study of 3'-Deoxy-3'-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688. Kostakoglu L; Duan F; Idowu MO; Jolles PR; Bear HD; Muzi M; Cormack J; Muzi JP; Pryma DA; Specht JM; Hovanessian-Larsen L; Miliziano J; Mallett S; Shields AF; Mankoff DA; J Nucl Med; 2015 Nov; 56(11):1681-9. PubMed ID: 26359256 [TBL] [Abstract][Full Text] [Related]
26. Optimal transformations leading to normal distributions of positron emission tomography standardized uptake values. Scarpelli M; Eickhoff J; Cuna E; Perlman S; Jeraj R Phys Med Biol; 2018 Jan; 63(3):035021. PubMed ID: 29235988 [TBL] [Abstract][Full Text] [Related]
27. [18F]3'-deoxy-3'-fluorothymidine-PET in NHL patients: whole-body biodistribution and imaging of lymphoma manifestations--a pilot study. Buchmann I; Neumaier B; Schreckenberger M; Reske S Cancer Biother Radiopharm; 2004 Aug; 19(4):436-42. PubMed ID: 15453958 [TBL] [Abstract][Full Text] [Related]
28. PET with [18F]fluorothymidine for imaging of primary breast cancer: a pilot study. Smyczek-Gargya B; Fersis N; Dittmann H; Vogel U; Reischl G; Machulla HJ; Wallwiener D; Bares R; Dohmen BM Eur J Nucl Med Mol Imaging; 2004 May; 31(5):720-4. PubMed ID: 14991243 [TBL] [Abstract][Full Text] [Related]
29. Repeatability of Lodge MA; Holdhoff M; Leal JP; Bag AK; Nabors LB; Mintz A; Lesser GJ; Mankoff DA; Desai AS; Mountz JM; Lieberman FS; Fisher JD; Desideri S; Ye X; Grossman SA; Schiff D; Wahl RL J Nucl Med; 2017 Mar; 58(3):393-398. PubMed ID: 27688473 [TBL] [Abstract][Full Text] [Related]
30. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors. Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557 [TBL] [Abstract][Full Text] [Related]
31. 18F-FLT PET during radiotherapy or chemoradiotherapy in head and neck squamous cell carcinoma is an early predictor of outcome. Hoeben BA; Troost EG; Span PN; van Herpen CM; Bussink J; Oyen WJ; Kaanders JH J Nucl Med; 2013 Apr; 54(4):532-40. PubMed ID: 23345303 [TBL] [Abstract][Full Text] [Related]
32. Reproducibility of quantitative 18F-3'-deoxy-3'-fluorothymidine measurements using positron emission tomography. de Langen AJ; Klabbers B; Lubberink M; Boellaard R; Spreeuwenberg MD; Slotman BJ; de Bree R; Smit EF; Hoekstra OS; Lammertsma AA Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):389-95. PubMed ID: 18931838 [TBL] [Abstract][Full Text] [Related]
33. Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer. van Westreenen HL; Cobben DC; Jager PL; van Dullemen HM; Wesseling J; Elsinga PH; Plukker JT J Nucl Med; 2005 Mar; 46(3):400-4. PubMed ID: 15750150 [TBL] [Abstract][Full Text] [Related]
34. Prospective evaluation of pretreatment and intratreatment FDG PET-CT SUV stability in primary head and neck cancer. Mendez LC; Conrad T; Lee J; Smith B; Brotherston D; Le T; Kiss A; Caldwell CB; Karam I; Poon I Head Neck; 2019 Jun; 41(6):1889-1894. PubMed ID: 30688385 [TBL] [Abstract][Full Text] [Related]
35. Clinical usefulness of [18F] fluoro-2-deoxy-D-glucose uptake in 178 head-and-neck cancer patients with nodal metastasis treated with definitive chemoradiotherapy: consideration of its prognostic value and ability to provide guidance for optimal selection of patients for planned neck dissection. Inokuchi H; Kodaira T; Tachibana H; Nakamura T; Tomita N; Nakahara R; Takada A; Mizoguchi N; Tamaki T; Fuwa N Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):747-55. PubMed ID: 20434274 [TBL] [Abstract][Full Text] [Related]
36. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369 [TBL] [Abstract][Full Text] [Related]
37. Effect of Platinum-Based Chemoradiotherapy on Cellular Proliferation in Bone Marrow and Spleen, Estimated by (18)F-FLT PET/CT in Patients with Locally Advanced Non-Small Cell Lung Cancer. Leimgruber A; Möller A; Everitt SJ; Chabrot M; Ball DL; Solomon B; MacManus M; Hicks RJ J Nucl Med; 2014 Jul; 55(7):1075-80. PubMed ID: 24868108 [TBL] [Abstract][Full Text] [Related]
39. Detection of gastric cancer using 18F-FLT PET: comparison with 18F-FDG PET. Kameyama R; Yamamoto Y; Izuishi K; Takebayashi R; Hagiike M; Murota M; Kaji M; Haba R; Nishiyama Y Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):382-8. PubMed ID: 18985344 [TBL] [Abstract][Full Text] [Related]
40. Comparison of ( 18 ) F-FLT PET and ( 18 ) F-FDG PET for detection of cervical lymph node metastases in head and neck cancers. Hoshikawa H; Kishino T; Mori T; Nishiyama Y; Yamamoto Y; Inamoto R; Akiyama K; Mori N Acta Otolaryngol; 2012 Dec; 132(12):1347-54. PubMed ID: 22992199 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]